Low-cost mass production. Contract service for recombinant protein production using recombinant rice seeds.
Preventec Co., Ltd. "Production of recombinant proteins using recombinant rice seeds" provides high-quality cytokines and cell growth factors produced from recombinant rice. It takes about a year and a half to create recombinant rice and cultivate homozygous lines (F2 generation), but once recombinant rice (F2 generation) is established, there are significant advantages in large-scale production and reproduction compared to other protein production methods. Contract services allow for scale-up and cost reduction. 【Features】 ○ No contamination with human pathogens ○ No contamination with bacterial or animal components ○ Low production costs ○ Easy large-scale production For more details, please contact us or download the catalog.
Inquire About This Product
basic information
【Summary】 ○ Equipment (Running costs & maintenance): Low cost ○ Manufacturing method (Raw material separation & sorting): Low cost & light labor ○ Safety → Bacterial toxins: No contamination risk → BSE & viruses: No contamination risk ○ Technology (Patents & novelty): Competitive globally ○ Delivery time (Initial production/ Reproduction): 2 years / 4 months ○ Manufacturing cost (10g of protein): 25,000 yen ○ Storage: Recombinant rice grains ● For more details, please contact us or download the catalog.
Price information
Please contact us.
Delivery Time
※Please contact us.
Applications/Examples of results
For more details, please contact us or download the catalog.
catalog（1）
Download All Catalogs
Company information
Preventec Co., Ltd. is a bio-venture company that develops the production of useful substances using a high-expression system of proteins derived from rice seeds. We provide high-quality cytokines and cell growth factors produced from recombinant rice, conduct research and development on methods for controlling inflammation and allergies, and aim to commercialize products in skincare and healthcare. We aspire to contribute to the promotion of the bio-industry by developing new applications for antibodies and other substances.
